Very long chain fatty acids activate NADPH oxidase in human dermal fibroblasts

Cell Biochemistry and Function

Volumn 23, Issue 1, 2005, Pages 65-68

  Dhaunsi, Gursev S ^a   Kaur, Jaspal ^b   Alsaeid, Khaled ^a   Turner, Ronald B ^b   Bitar, Milad S ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Fibroblasts; Lipid peroxidation; NADPH oxidase; Peroxisome; Superoxide; VLCFAs

Indexed keywords

FATTY ACID; LIGNOCERIC ACID; MESSENGER RNA; PROTEIN P22; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE;

ARTICLE; CONTROLLED STUDY; DISORDERS OF PEROXISOMAL FUNCTIONS; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CELL;

ACETOPHENONES; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME INHIBITORS; FATTY ACIDS; FIBROBLASTS; HUMANS; MALONDIALDEHYDE; NADPH OXIDASE; PALMITIC ACID; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDE DISMUTASE;

EID: 11244256702     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1173     Document Type: Article

References (23)

1. Van Den Bosch H, Schutgens R, Wanders RJA, Tager J. Biochemistry of peroxisomes. Ann Rev Biochem 1992; 61: 157-197.
2. Poggi-Travert F, Fournier B, Poll-The BT, Saudubray JM. Clinical approach to inherited peroxisomal disorders. J Inher Metab Dis 1995; 18: 1-18.
3. Schutgens RBH, Heymans HAS, Wanders RJA, Van den Bosch H, Tager JM. Peroxisomal disorders: a newly recognized group of genetic diseases. Eur J Ped 1986; 144: 430-440.
4. Moser HW. Peroxisomal disorders. Clin Biochem 1991; 24: 343-351.
5. Brown FR, Voigt R, Singh AK, Singh I. Peroxisomal disorders: neurodevelopmental and biochemical aspects. Am J Dis Child 1993; 147: 617-626.
6. Singh I. Peroxisomal fatty acid oxidation and cellular oxidative stress. Method Enzymol 2002; 352: 361-372.
7. Kremser K, Kovacs W, Stangl H. Peroxisomal diseases - oxygen and free radicals. Wien Klin Wochenscher 1995; 107: 690-693.
8. DeLeo FR, Quinn MT. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J Leukoc Biol 1996; 60: 677-691.
9. Chabrashvili T, Tojo A, Onozato ML, et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 2002; 39: 269-274.
10. Lambeth JD, Cheng G, Arnold RS, Edens WE. Novel homologs of gp91phox. Trends Biochem Sci 2000; 25: 459-461.
11. Segal BH, Leto TL, Gallin JI, Malech HI, Holland SM. Genetic, biochemical and clinical features of chronic granulomatous disease. Medicine 2000; 79: 170-200.
12. Byrne JA, Greive DJ, Bendall JK, et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 2003; 93: 802-805.
13. Cheng G, Cao Z, Xu X, Van Meir EG, Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox 4, and Nox5. Gene 2001; 269: 131-140.
14. Bell M, Sikka S, Rajasekaran M, Hellstrom W. Time course of hydrogen peroxide-induced changes in the lipid peroxidation of human sperm membranes. Adv Contracept Deliv Syst 1992; 8: 144-150.
15. Bengtsson SH, Gulluyan LM, Dusting GJ, Drummond GR. Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology. Clin Exp Pharmacol Physiol 2003; 30: 849-854.
16. Perichon R, Bourre JM, Kelly JF, Roth GS. The role of peroxisomes in aging. Cell Mol Life Sci 1998; 54: 641-652.
17. Bokoch GM, Knaus UG. NADPH oxidases: not just for leukocytes anymore. Trends Biochem Sci 2003; 28: 502-508.
18. Bleeke T, Zhang H, Madamanchi N, Patterson C, Faber JE. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 2004; 94: 37-45.
19. Selishcheva AA, Atruz OM, Sorokoumova GM, Skrjabin GA, Vasilenko IA, Chuchalin AG. Effects of liposomes of different phospholipids composition on the induction of respiratory burst in human blood monocytes and alveolar macrophages. Membr Cell Biol 2001; 14: 637-647.
20. Holland JA, Meyer JW, Schmitt ME, et al. Low-density lipoprotein stimulated peroxide production and endocytosis in cultured human endothelial cells: mechanisms of action. Endothelium 1997; 5: 191-207.
21. Bromberg Y, Sha'ag D, Shpungin S, Pick SE. Activation of the superoxide forming NADPH oxidase I a macrophage-derived cell-free system by fatty acids and detergents. Adv Prostaglandin Thromoxane Leukotriene Res 1986; 16: 153-163.
22. Pattison DI, Dean RT, Davies MJ. Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s. Toxicology 2002; 177: 23-37.
23. Verhoeven AJ, Bolscher MG, Roos D. The superoxide-generating enzyme in phagocytes: physiology, protein composition, and mechanism of activation. In Membrane Lipid Oxidation, Vigo-Pelfrey C (ed.). CRC Press: Boston; 1991; 42-59.